NEFL and early-onset autosomal dominant Alzheimer disease: Recent randomized controlled trial evidence shows that 12-month supplementation with combined omega-3 fatty acids significantly reduced plasma NFL levels - a blood marker of axonal injury - in individuals with mild cognitive impairment, suggesting a potential neuroprotective effect in early Alzheimer’s disease (Remoli et al., 2021).